DXCM DexCom Inc

DexCom, Inc recently received FDA approval for their new G7 continuous glucose monitor The improved device–and the relationships it is helping them build-show great promise for the future. DexCom stock has been struggling, but this news may be a catalyst. DexCom, Inc. (NASDAQ:DXCM) is a continuous glucose monitoring (CGM) company. In early December, they received approval […]
https://www.valuewalk.com/can-fda-approval-bolster-dexcom/